|
KMID : 1145520180040020099
|
|
Journal of Radiopharmaceuticals and Molecular Probes
2018 Volume.4 No. 2 p.99 ~ p.105
|
|
|
211At and 211At-labeled radiopharmaceuticals for targeted alpha therapy
|
|
Kang Choong-Mo
Lee Kyo-Chul
Lee Yong-Jin
|
|
|
Abstract
|
|
|
|
211At is an alpha emitting radionuclide, which can be produced using cyclotron with alpha beam. In addition, its strong linear energy transfer and iodine-like chemistry make that 211At is one of the most attractive radionuclide in the field of targeted alpha therapy. In this review, production, labeling, and radiopharmaceuticals of 211At will be discussed
|
|
|
KEYWORD
|
|
|
211At, Astatine, Targeted alpha therapy, Radiotherapy, Alpha particle
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|